ArticleBone marrow transplantation2026

Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC.

Víctor Galán-Gómez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.